Emami Saeed, Foroumadi Alireza
Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Arch Pharm (Weinheim). 2009 Sep;342(9):541-5. doi: 10.1002/ardp.200900024.
A new series of 3-imidazolyl-substituted flavan derivatives being equipped with a N-(phenethyl)-azole scaffold as the common pharmacophore of azole antifungals, were synthesized. The stereochemical and conformational properties of compounds were also characterized by (1)H-NMR data. The results of the antifungal evaluation of trans-3-imidazolyl-substituted flavan-4-ones and (Z)-trans-3-imidazolyl-substituted flavan-4-one oximes in comparison with the reference drug fluconazole indicated that most target compounds possessed significant in-vitro antifungal activities against the tested fungi, comparable or superior to fluconazole.
合成了一系列新型的3-咪唑基取代的黄烷衍生物,这些衍生物带有N-(苯乙基)-唑骨架,作为唑类抗真菌剂的共同药效基团。还通过(1)H-NMR数据对化合物的立体化学和构象性质进行了表征。与参考药物氟康唑相比,反式-3-咪唑基取代的黄烷-4-酮和(Z)-反式-3-咪唑基取代的黄烷-4-酮肟的抗真菌评价结果表明,大多数目标化合物对测试真菌具有显著的体外抗真菌活性,与氟康唑相当或优于氟康唑。